European Loans: An attractive investment proposition

Governments and Central Banks continue to implement loose monetary policy and expansionary fiscal stimulus in response to the Covid-19 pandemic, inflationary pressure is rising within global markets. Consequently, treasury yield curves have steepened and the downward pressure on rates is easing. Fixed income investors are increasingly concerned about duration risk and this has already translated into heaviness in long duration assets. Overarching all of this is the persistence of low yields; 60% of Global Fixed Income is still yielding less than 1%, so the reach for yield remains a key goal. In the hunt for yield, prey is scarce, European Loans are a viable target.

With steepening yield curves and firmer base rates shorter duration assets like European Loans have fared well, benefitting from the potential of increased future income from their floating rate coupon component. Moreover, we think this theme will persist through the year. YTD 2021 European Loans are outperforming traditional Fixed Income asset classes, but this isn’t a one off. European Loans have outperformed comparable fixed income asset classes in several previous rising rate environments.

One of the reasons for this outperformance is due to greater levels of private equity support received. Contributions from sponsors on new transactions are at all-time highs averaging 52% in 2020 vs 33% in 2007. This combined boost from a top-down and bottom up perspective was crucial in restoring liquidity and curbing defaults. At this point it is worth mentioning that loans have the additional benefit of typically sitting senior in the capital structure to High Yield and being secured against assets. Importantly interest coverage has increased to 4.7x, the highest level ever seen. Though European Loan defaults increased to 2.57% in 2020 from 0.44% in 2019, this is still below long term default levels; and well below the 8% default forecast at the beginning of the pandemic.

Looking forward, fundamentals are on the mend for many sectors and the speed of the vaccination rollout will determine the performance of European economies and especially COVID-sensitive sectors. For 2021 there is consensus that both sponsor and government support will continue, and given the abundant market liquidity, we expect to see a more benign default rate of 2-4% for European Loans.

Another positive tailwind has been the steady growth of the asset class, since 2007 it has grown from €100bn to over €320bn in 2020 improving the supply and demand dynamics of the asset class. Its depth and liquidity is largely comparable to European High Yield in recent years.

In terms of income European Loan returns did compress over 2007 to 2010 but have been relatively stable since then, averaging in the 4-5% range despite negative base rates, in contrast to the continued year on year compression in Fixed Income markets. Whilst capital returns have experienced significant volatility due to the pandemic the asset class has largely recovered, albeit the average price for European Loans is c.98 (30th Apr 2021), so the potential for a pull to par remains.

Compared to most credit asset classes, European Loans arguably fulfils the fundamental objective of Fixed Income better than most, stable strong income streams with the potential of additional upside via price appreciation.

For more on this please follow the link below that leads to the European Loans paper we published last month.

https://www.alcentra.com/

Europaische Loans – Eine zweiseitige Absicherung der Zinssatze

European Loans – a two way rate hedge

Silvia Mischel
Director Institutional Sales
T +49 (0) 69 / 12014 1605
M +49 (0) 162 / 2990 129
Silvia.Mischel@bnymellon.com

BNY Mellon Fund Management (Luxembourg) S.A.
Zweigniederlassung Deutschland
MesseTurm
Friedrich-Ebert-Anlage 49
60308 Frankfurt am Main
Deutschland

www.bnymellonim.de

www.alcentra.com/


|
This article is based on information provided by BNY Mellon (sponsored content).   

All opinions expressed are those of the author.

 

This is a financial promotion and is not intended as investment advice. The information provided within is for use by professional investors and/or distributors and should not be relied upon by retail investors.

The Bank of New York Mellon Corporation (“BNY Mellon”) holds the majority of The Alcentra Group (or “Alcentra”), which is comprised of the following affiliated companies: Alcentra Ltd. and Alcentra NY, LLC. Assets under management include assets managed by both companies. Alcentra NY, LLC and Alcentra Ltd. are registered with the U.S. Securities & Exchange Commission under the Investment Advisers Act of 1940.

Alcentra Ltd is authorized and regulated by the Financial Conduct Authority – Registration number 196845 – and regulated by the Securities Exchange Commission – Registration number 801-74223. Registered office for Alcentra Ltd is 160 Queen Victoria Street, London, EC4V 4LA, UK. Alcentra NY, LLC is regulated by the Securities Exchange Commission – Registration number 801-62417. Registered office for Alcentra NY, LLC is 200 Park Avenue, New York, NY 10166, USA.

BNY Mellon Fund Management (Luxembourg) S.A. (“BNY MFML”) is authorised to issue this document for marketing purposes only to Professional Clients in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Ireland, Luxembourg, Netherlands, Norway, Spain, Portugal and Sweden. BNY MFML Registered Office: 2-4 Rue Eugène Ruppert L-2453 Luxembourg. Registered in Luxembourg with number B28166. Authorised and regulated by the Commission de Surveillance du Secteur Financier.

BNY Mellon Investments Switzerland GmbH is authorised to issue this document in Switzerland to Qualified Investors only. Registered Office: Talacker 29, CH-8001 Zürich, Switzerland. Authorised and regulated by the FINMA. Neither BNY MFML or BNY Mellon Investments Switzerland GmbH will provide investment advice in connection with the products mentioned in this document and are not responsible for any subsequent investment advice given based on the information supplied.

Key Risks

Unless you are notified to the contrary, the services mentioned are not insured by the FDIC (or by any governmental entity) and are not guaranteed by or obligations of BNY Mellon NA or any of its affiliates. BNY Mellon NA assumes no responsibility for the accuracy or completeness of the above data and disclaims all expressed or implied warranties in connection therewith. © 2021 The Bank of New York Mellon Corporation. All rights reserved.

 

This document is proprietary and not to be reproduced or redistributed in whole or in part without the prior written consent of Alcentra.

Past performance is not indicative of future results.

The value of investments and the income from them is not guaranteed and can fall as well as rise due to market and currency movements.

A potential client should consider the strategy’s investment objectives, risks, charges and expenses carefully before investing. Portfolios are subject to investment risks, including possible loss of the principal amount invested. Material in this publication is for general information only and is not intended to provide specific investment advice or recommendations for any purchase or sale of any specific security or commodity.

Investments in sub-investment grade debt are speculative and involve special risks, and there can be no assurance that an account’s investment objectives will be realized or that suitable investments may be identified. Many factors affect performance including changes in market conditions and interest rates and in response to other economic, political, or financial developments. An investor could lose all or a substantial portion of his or her investment. No investment process is free of risk and there is no guarantee that the investment process described herein will be profitable. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment.

All views, opinions and estimates in this document constitute the best judgment of Alcentra as of the date hereof, but are subject to change without notice, and do not necessarily represent the views of Alcentra. The information in this document may contain projections or other forward-looking statements regarding future events, targets or expectations regarding the strategies described herein (including those introduced by the terms “may,” “target,” “expect,” “believe,” “will,” “should” or similar terms). There is no assurance that such events or targets will be achieved, and may be significantly different from that shown here. The information in this presentation, including statements concerning financial market trends, is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons.

Certain information contained herein is based on outside sources believed to be reliable, but its accuracy is not guaranteed.

The information in this document is only as current as the date indicated, and may be superseded by subsequent market events or for other reasons. Nothing contained herein constitutes investment, legal, tax or other advice nor is it to be relied on in making an investment or other decision. Investors should independently investigate any investment strategy or manager, and consult with qualified investment, legal, and tax professionals before making an investment.

This material has been provided for informational purposes only and should not be construed as investment advice or a recommendation of any particular investment product, strategy, investment manager or account arrangement, and should not serve as a primary basis for investment decisions.  Prospective investors should consult a legal, tax or financial professional in order to determine whether any investment product, strategy or service is appropriate for their particular circumstances.